Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W Johnson

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Mayo Clinic Proceedings. Digital Health|April 10, 2025
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational StudyDemilade Adedinsewo, Jennifer Dugan, Patrick W Johnson, et al.
Acta Neuropathologica Communications|July 14, 2022
Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measuresRebecca R Valentino, Chloe Ramnarine, Michael G Heckman, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 16, 2023
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening ScorePatrick W Johnson, Katie L Kunze, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|May 7, 2021
Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical CenterRickey E Carter, Elitza S Theel, Laura E Breeher, et al.
Brain : a Journal of Neurology|March 17, 2025
Genome-wide association study of neuropathological features in Lewy body diseaseRebecca R Valentino, Shunsuke Koga, Alexandra I Soto-Beasley, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Nature Medicine|February 5, 2025
Author Correction: Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trialDemilade A Adedinsewo, Andrea Carolina Morales-Lara, Bosede B Afolabi, et al.
Nature Medicine|September 2, 2024
Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trialDemilade A Adedinsewo, Andrea Carolina Morales-Lara, Bosede B Afolabi, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Mayo Clinic Proceedings. Digital Health|April 10, 2025
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational StudyDemilade Adedinsewo, Jennifer Dugan, Patrick W Johnson, et al.
Acta Neuropathologica Communications|July 14, 2022
Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measuresRebecca R Valentino, Chloe Ramnarine, Michael G Heckman, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 16, 2023
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening ScorePatrick W Johnson, Katie L Kunze, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|May 7, 2021
Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical CenterRickey E Carter, Elitza S Theel, Laura E Breeher, et al.
Brain : a Journal of Neurology|March 17, 2025
Genome-wide association study of neuropathological features in Lewy body diseaseRebecca R Valentino, Shunsuke Koga, Alexandra I Soto-Beasley, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Nature Medicine|February 5, 2025
Author Correction: Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trialDemilade A Adedinsewo, Andrea Carolina Morales-Lara, Bosede B Afolabi, et al.
Nature Medicine|September 2, 2024
Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trialDemilade A Adedinsewo, Andrea Carolina Morales-Lara, Bosede B Afolabi, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 8